– Nigeria Misses First Phase Of Pfizer Vaccine
– Expects 16 m Doses Of Astrazeneca Vaccine By February– NPHCDA Employer
The World Health Organisation, (WHO), yesterday stated it has not disqualified Nigeria or any African nation from accessing COVID-19 vaccines through the COVAX center. Rather, it is supporting all countries to access vaccines as quickly as possible.
However, Nigeria has missed out on the very first stage of the Pfizer COVID-19 vaccine, as the 100,000 dosages of the Pfizer vaccine anticipated to show up the nation this month has actually been changed with 16 million doses of Astrazeneca vaccine.
The worldwide health body, through its Director, African Region, Dr. Matshidiso Moeti, said on Thursday that about 320,000 dosages of the Pfizer-BioNTech vaccine have been designated to four African nations of Cape Verde, Rwanda, South Africa and Tunisia, with deliveries anticipated later on in February.
She kept in mind that to access a preliminary minimal volume of Pfizer vaccine, nations were welcomed to submit proposals. Their propositions were examined, based on existing death rates, brand-new cases and patterns and capacities to provide the vaccine, including keeping it at minus 70 degrees Celsius.
Nigeria, which is anticipating about 100,000 dosages of the vaccine this month, was not consisted of in the allowance. Instruction reporters on the purported disqualification of Nigeria from accessing COVID-19 vaccines, the other day, in Abuja, WHO Country Agent in Nigeria, Dr. Walter Kazadi Mulombo, stated the need for the preliminary allowance of 1.2 million dosages was extremely high. She explained that COVAX received interest from 72 nations, out of which 51 nations, consisting of Nigeria, were thought about ready by the review committee. Eighteen countries were lastly picked to get the preliminary dosages.
Mulombo stated in Africa continent, since January 18 due date, COVAX got 13 submissions and a multi-agency committee evaluated the propositions, out of which 9 were recommended as ready to release the Pfizer vaccine, including Nigeria. However, it was not practical to provide each of these 51 nations with Pfizer doses, due to a number of elements, consisting of the limited capability for Pfizer to handle numerous countries at once.
He said: “Spreading out the limited doses across all the 51 countries deemed ‘all set’ might have not accomplish the intended public health advantage. After epidemiological data was taken into account, the decision was required to proportionally stabilize the variety of self-financing and AMC participants, along with participants throughout all six WHO areas.”
Molumbo observed that currently, all countries on the continent are anticipated to begin accessing the AstraZeneca/Oxford vaccines by the end of February, adding that out of the 88 million AstraZeneca dosages assigned to African nations for the very first phase, Nigeria has received by far the biggest allowance, with 16 million doses.
” In addition to the AstraZeneca doses, there is an initial limited volume of Pfizer vaccine offered through COVAX. The vaccine is under review by WHO for Emergency Usage Listing and the outcome is anticipated soon,” he included.
The Executive Director, National Main Health Care Advancement Company (NPHCDA), Dr. Faisal Shuaib observed that a variety of elements were considered in assigning the little amount of the 320,000 dosages of Pfizer vaccine to COVAX countries, which include the mortality rates from COVID-19, the variety of brand-new cases, the trend in the number of cases, the population and the schedule of the appropriate Cold Chain equipment.
He stated, “countries such as South Africa which received the Pfizer allotment have the brand-new stress of the COVID-19 infection, has the highest death rates and is having a hard time to contain transmission. Providing smaller sized countries such as Cape Verde and Rwanda few dosages of the Pfizer vaccine would have a bigger public health effect considering their population. 100,000 dosages to Nigeria, we have all agreed would have been a drop in the ocean, so, it is a welcome advancement that we are getting 16 million dosages of the Astrazeneca vaccine to replace the Pfizer vaccine in February. The ultra cold chain equipment would have been able to save about 400,000 doses of the Pfizer vaccine. The 16 million dosages will invariably help us reach more people and is matched to our existing cold chain system.”
When asked about particular reasons Nigeria in specific was not included in the allowance for Pfizer vaccine, Shuaib said, “we were not part of the selection procedure; what they offered us was the requirements, South Africa has the highest death rate in Africa and other strains of the infection. They are struggling under the burden of this illness. If you give 100,000 doses to Nigeria that has over 200 million population, is it not a drop in the ocean? At this moment, the 100,000 doses initially suggested for Nigeria has been replaced with 16 million. The committee has actually looked at the context of different nations prior to coming out with their choice.”
The NPHCDA manager noted that the very first vaccine Nigeria will now get in February is the Astranzanica Covid-19 vaccine. “Health employees who are at the high threat of contracting this diseases, the elderly and those with underlying diseases will be the very first to get the vaccines.
Shuaib revealed that the cold chain devices at the Primary Healthcare Centres will be utilized and that his organization will make sure that every ward gets one cold chain devices.
” We want to guarantee a successful roll out of the vaccines. These equipment can save over 400,000 doses of the Pfizer vaccine.
COVID-19 vaccine: WHO rejects disqualifying Nigeria
Get your Nigerian Health Breaking News Headlines Now & regional videos at Naija.NewsBurrow.com. Today as always, we peruse newest news headings to bring you significant viewpoints in your region in in-depth reports. Join the conversation, fulfill our social media fans . You can be part of us and help us poll and choose the videos you enjoy finest and news that concerns you . SUBSCRIBE for a FREE Profile to send and rank your stories and videos and conserve your reactions. MAKE YOUR VIEWPOINTS COUNT . Click here to subscribe or login Login/ Register